What Stemetil Treats: Main Uses and Benefits

Stemetil (Prochlorperazine) is applied across domains where additional symptomatic support is needed in situations where patients experience distressing symptoms. The medication is considered relevant for severe emesis, symptoms of schizophrenia, and short-term generalized non-psychotic anxiety. It is used in conditions presenting with acute or disruptive episodes, such as severe nausea and vomiting, debilitating vertigo and dizziness, and symptoms of psychosis or severe agitation.

The medication is commonly used when supportive relief is needed for acute symptomatic episodes, including sickness induced by chemotherapy or during acute vestibular attacks associated with Meniere's Syndrome. The support provided helps patients cope more steadily with symptom fluctuations that interfere with routine activities. This therapeutic benefit contributes to easing the overall symptom load and supports patients during difficult episodes by easing distress.

“It is commonly used to help with managing challenging manifestations and contributes to support general well-being during symptomatic phases.”

---

Quick Fact: Symptomatic Support
Primary Symptom Focus: Severe nausea and vomiting, vertigo, dizziness, and agitation.
Typical Use Context: Acute symptomatic support in oncology, vestibular, and certain psychiatric settings.
Patient Benefit: Assists with maintaining functional stability and contributing to improved comfort during periods of heightened symptoms.

Regulatory References

1. NIH MedlinePlus Drug Information

This section outlines the official population-eligibility rules and restrictions for Stemetil (Prochlorperazine) as defined in regulatory labeling.

Eligibility Scope

Category	Official Regulatory Status
Populations Allowed	Adults for approved indications. Children 2 years of age and older who weigh at least 9 kg (approx 20 lbs) for approved pediatric indications.
Populations Contraindicated	Patients with known hypersensitivity to Prochlorperazine or any other phenothiazine derivative. Individuals in comatose states, with circulatory collapse, or with bone marrow depression/blood dyscrasias. Children under 2 years of age or lt 9 kg (lt 20 lbs).

---

Age- and Condition-Specific Restrictions

Category	Regulatory Status
Age-Related Rules	Use is not approved for elderly patients with dementia-related psychosis due to increased mortality risk. Should be avoided in children whose symptoms suggest Reye’s Syndrome.
Physiological Status	Use is not recommended during pregnancy, especially the third trimester, due to risk of neonatal symptoms. Caution is required for patients with Liver or Renal dysfunction, epilepsy, severe cardiovascular disorders, and specific conditions like glaucoma or prostatic hypertrophy.

---

Connection to the overall eligibility profile: The official regulatory documents strictly limit the use of Prochlorperazine by establishing absolute contraindications for high-risk systemic conditions and CNS compromise. The labeling also imposes stringent age restrictions and mandates caution for populations with pre-existing conditions that affect organ function, ensuring adherence to its defined risk profile.

Interactions with other medicines and products

Formally Contraindicated Combinations

Co-administration is formally prohibited in the presence of large amounts of central nervous system (CNS) depressants, including alcohol, barbiturates, and narcotics. This regulatory restriction is due to the risk of intensifying or prolonging CNS depression.

Pharmacodynamic and Neurological Effects

Other agents carry a risk of additive effects. Phenothiazines, the drug class to which this medicine belongs, may intensify the action of Anesthetics. Combining the medicine with Lithium has a documented possible causal relationship with an encephalopathic syndrome (neurological toxicity). Additionally, co-administration with Anticholinergic Medications may result in heightened additive anticholinergic effects.

Exposure and Metabolic Interactions

Pharmacokinetic data shows that for the extended-release capsule formulation, co-administration with food reduces systemic exposure, decreasing both the maximum plasma concentration (Cmax) and the area under the curve (AUC). The metabolism of the oral medicine occurs via the Cytochrome P450 enzyme system, specifically involving the CYP2D6 enzyme for oxidation.

Clinical and Procedural Constraint

The antiemetic action of this medicine may mask the signs and symptoms of overdosage of other medicines. This function also means it may obscure vomiting as a critical sign of toxicity from certain agents, such as cancer chemotherapeutic drugs. Consistent with regulatory class warnings, the use of antipsychotic medicines is associated with an increased risk of death in elderly patients with dementia-related psychosis.

Stemetil (prochlorperazine) functions primarily as a centrally acting antagonist at multiple neurotransmitter receptors, exerting its predominant effect via the dopaminergic system. The compound selectively targets and blocks postsynaptic dopamine D2 receptors in the central nervous system, including those localized within the chemoreceptor trigger zone (CTZ) in the medulla. This D2 receptor blockade inhibits dopamine-mediated signal transduction, which reduces neuronal activity in this system. The resulting decrease in signaling propagates to the adjacent brainstem nuclei, modulating the efferent pathways.

Beyond its primary action, prochlorperazine also exhibits affinity as an antagonist at several other receptor types. These include Histamine H1 receptors, alpha1-adrenergic receptors, and muscarinic cholinergic receptors. Interaction with these additional targets further contributes to the overall modulation of signal flow across diverse neural circuits, which collectively impacts autonomic and central nervous system output.

Administration Methods

Stemetil is available in several formulations, including oral tablets and solution for injection. The method of administration depends on the specific form prescribed and the condition being addressed.

Oral Tablets

Tablets are typically swallowed whole with a glass of water. They can generally be taken with or without food, though consistency in how they are taken may help maintain steady levels of the medication in the body.

Solution for Injection

The injectable form of Stemetil is administered by a healthcare professional. It is usually given as a deep intramuscular injection. This route is often utilized when a rapid effect is required or when oral administration is not feasible.

General Usage Considerations

To ensure the medication functions as intended, it is important to follow the specific schedule provided by a healthcare provider.

• Consistency: Taking the medication at the same time each day helps maintain a constant level in the bloodstream.
• Duration: The length of time this medication is used varies significantly based on the individual's response and the nature of the symptoms.
• Handling: Tablets should be kept in their original packaging until use to protect them from light and moisture.

Research Evidence / Overview of Studies for Stemetil

---

Evidence for Use in Acute Nausea and Vomiting

Research exploring how symptoms change over time often focuses on this medicine in research contexts involving acute nausea and vomiting. Randomized Controlled Trials (RCTs) have been conducted to evaluate its patterns of effect, often involving active-controlled designs where measured outcomes were compared. These studies primarily measure outcomes related to physical discomfort, such as the time until vomiting stops and the level of nausea intensity reported by the patient.

What remains uncertain is the durability of the outcomes measured during the study period. Because most research is designed to examine temporary physiological imbalance and acute relief, follow-up durations were limited, often focusing solely on the first few hours post-administration. Data for certain groups, such as children, remain less extensive, contributing to a body of evidence where certainty remains low for certain subgroups.

Evidence for Use in Acute Migraine and Vertigo

The evidence includes RCTs and systematic reviews that have explored this medicine in research contexts involving acute conditions of headache pain, specifically tracking the duration of sustained relief. Most headache research focuses on administration via injection in controlled settings, meaning fewer data exist regarding outcomes using other forms.

The body of evidence related to conditions involving periods of heightened symptoms like vertigo includes short-term, placebo-controlled studies. Data show patterns related to the measured change in reported dizziness and nausea intensity. However, a key research gap is the mechanistic clarification: it is not yet definitively established whether the research-described outcomes are due to a direct effect on the system that controls balance or are secondary to the effect observed on nausea and vomiting symptoms.

Limitations and Unanswered Questions

The evidence highlights what is known but also what is still uncertain. Evidence quality varies across studies, and limitations include the short follow-up durations and modest sample sizes in some research contexts, particularly for the use in Generalized Non-Psychotic Anxiety. For this application, the existing research is characterized by short follow-up periods, and Evidence is limited compared to its anti-emetic applications. Comparative evidence is lacking for many non-acute uses. In all cases, the research provides context but not individual predictions, and the findings reflect group patterns under specific study conditions.

Key Studies & References

1. The Acute Treatment of Migraine: Assessment of Migraine Pharmacotherapies (Guideline/Review)
2. Headaches in over 12s: diagnosis and management (NICE guideline CG150 - Update on Acute Migraine)
3. PROCHLORPERAZINE IN ANXIETY (Short-term anxiety trial)

Common questions about Stemetil (FAQ)

---

Q: How quickly does Stemetil start working for dizziness?

A: The onset of the anti-vertigo effect depends on the formulation. Official product information indicates that mathbforal mathbftablets typically begin working in mathbf30 to mathbf40 mathbfminutes. If administered by mathbfintramuscular mathbfinjection, the effect may be noted faster, usually within mathbf10 to mathbf20 mathbfminutes.

Q: What are the most common side effects people report when taking Stemetil?

A: Official safety documents list several commonly reported side effects. These commonly include effects like mathbfdrowsiness and mathbfblurred mathbfvision. Other common effects include mathbfdry mathbfmouth, mathbfconstipation, and involuntary muscle movements such as mathbftremor or mathbfdyskinesia.

Q: Can Stemetil cause dry mouth or blurred vision?

A: Yes, regulatory documents confirm that both mathbfdry mathbfmouth and mathbfblurred mathbfvision are documented as known side effects. These effects are related to the medication's anticholinergic properties.

Q: Can Stemetil be taken with food, or does it need to be on an empty stomach?

A: Standard oral tablets can generally be taken mathbfwith mathbfor mathbfwithout mathbffood. However, official information for the mathbfextended-release mathbfcapsule formulation notes that taking it with food may mathbfreduce the amount of the drug available for absorption.

Q: What happens if I miss a dose of Stemetil?

A: Official guidance describes that if a dose is missed, regulatory protocols often suggest mathbfskipping mathbfthe mathbfmissed mathbfdose and taking the next scheduled dose at the usual time. The guidance also states that patients should mathbfavoid mathbftaking a double dose to compensate for the missed one.

Q: What is the general safety profile of Stemetil?

A: The medicine is classified as a mathbffirst-generation mathbfantipsychotic and is associated with the risk of mathbfserious mathbfside mathbfeffects (e.g., TD and NMS). Its use is mathbfcontraindicated in patients with specific conditions like coma or severe CNS depression.

Q: Is Stemetil a short-term or a long-term treatment?

A: It is generally advised to be used for the mathbfshortest mathbfpossible mathbftime that manages symptoms. For applications like non-psychotic anxiety, the duration of use is formally limited to a mathbfmaximum mathbfof mathbf12 mathbfweeks in official documents.

Q: Do I need to avoid driving while taking Stemetil?

A: Official warnings state that the medication mathbfmay mathbfimpair mathbfmental mathbfand/or mathbfphysical mathbfabilities, especially due to mathbfdrowsiness or mathbfdizziness. Patients are advised to mathbfavoid mathbfdriving or operating machinery until they are aware of how the medicine affects them.

Q: Can I take Stemetil if I am taking medication for heartburn?

A: The medicine has mathbfanticholinergic mathbfproperties. Caution is advised with co-administration of other drugs that also have anticholinergic effects (which may include certain heartburn medications), as this mathbfmay mathbfincrease mathbfside mathbfeffects like dry mouth and constipation.

Q: What are the known severe or rare side effects of Stemetil?

A: Regulatory documents list several serious, though rare, adverse reactions. These include mathbfNeuroleptic mathbfMalignant mathbfSyndrome mathbf(NMS), mathbfTardive mathbfDyskinesia mathbf(TD), mathbfseizures, and an increased risk of mathbfblood mathbfclots mathbf(VTE).

Q: Does Stemetil interact with birth control pills?

A: Official guidance from regulatory bodies like the NHS indicates that Prochlorperazine mathbfdoes mathbfnot mathbfaffect mathbfany mathbftype mathbfof mathbfcontraception, including the combined oral pill.

Q: Is Stemetil used for headaches or migraines?

A: Yes, official indications and clinical sources list the use of Prochlorperazine to treat mathbfnausea mathbfassociated mathbfwith mathbfmigraine and certain types of headache pain.

Q: Is Stemetil considered a strong or a weak medication?

A: The drug is officially classified as a mathbffirst-generation mathbfantipsychotic that also possesses strong mathbfantiemetic properties. It is also described as having mathbfweak mathbfsedative mathbfactivity compared to some other medicines in its class.

Q: What is the difference between Stemetil and other motion sickness tablets?

A: Prochlorperazine is a mathbfphenothiazine that works primarily by blocking mathbfdopamine mathbfD2 mathbfreceptors in the brain, which is a different mechanism from many common antihistamine-based motion sickness tablets. The regulatory information indicates that the drug is mathbfnot mathbfindicated or mathbfconsidered mathbfeffective for treating motion sickness.

Q: Is Stemetil available over the counter?

A: Official documents provide detailed mathbfprescribing mathbfinformation and confirm that Prochlorperazine is classified as a mathbfprescription mathbfonly mathbfmedicine (mathbfPOM) by regulatory bodies.

Q: Can Stemetil affect my mood or cause depression?

A: Changes in mood and mental state are possible side effects. While not universal, some reports indicate the possibility of adverse effects like mathbfagitation, mathbfanxiety, or mathbfdepression.

Q: Is it safe to take Stemetil if I have high blood pressure?

A: Official regulatory guidance states that mathbfcaution mathbfis mathbfrequired in patients with mathbfhigh mathbfblood mathbfpressure mathbf(hypertension) or severe cardiovascular disease. This is because the drug may influence cardiovascular function.

Q: What kind of studies have been done on Stemetil for balance issues?

A: Official indications list the use of this medicine for mathbfvertigo and mathbfLabyrinthitis (an inner ear infection affecting balance). Therefore, research has focused on the drug's effect on symptoms related to these mathbfbalance mathbfissues.

Q: Does Stemetil interact with common pain relievers like ibuprofen?

A: Authoritative drug interaction checkers indicate that mathbfno mathbfformal mathbfinteraction is mathbfestablished between Prochlorperazine and nonsteroidal anti-inflammatory drugs (NSAIDs) such as mathbfibuprofen. However, patients should confirm interactions involving their specific pain reliever.

Q: Is Stemetil similar to medications used for anxiety?

A: Yes, Prochlorperazine is mathbfformally mathbfindicated for the mathbfshort-term mathbfmanagement mathbfof mathbfnon-psychotic mathbfanxiety. This indication is listed alongside its uses for nausea and psychotic disorders.

Q: How long does the effect of one dose of Stemetil last?

A: The duration of effect varies by formulation. The effect of a single mathbforal mathbfdose typically lasts for mathbfapproximately mathbf6 mathbfhours. mathbfIntramuscular mathbfinjections or mathbfsuppositories typically last for mathbf3 to mathbf4 mathbfhours.

Q: Is Stemetil addictive or habit-forming?

A: The medicine is mathbfnot mathbfclassified mathbfas mathbfhabit-forming. However, after mathbfprolonged mathbfuse, the body may develop mathbfphysical mathbfdependence, requiring mathbfgradual mathbfwithdrawal to prevent mathbfdiscontinuation mathbfsymptoms such as nausea or difficulty sleeping.

Q: Are there any food or drink restrictions while taking Stemetil?

A: Co-administration with mathbflarge mathbfamounts mathbfof mathbfalcohol is mathbfprohibited due to the risk of intensifying central nervous system depression. Some sources also advise avoiding taking mathbfcalcium or mathbfiron mathbfsupplements for several hours around the time of the dose.

Q: Why is Stemetil prescribed for different conditions like vertigo and nausea?

A: Prochlorperazine is prescribed for multiple conditions because its classification as a mathbfphenothiazine gives it a mathbfbroad mathbfaction on mathbfmultiple mathbfneurotransmitter mathbfreceptors in the central nervous system. This affects both the mathbfvomiting mathbfcenter (for nausea) and the mathbfvestibular mathbfsystem (for vertigo).

Q: What is Stemetil used for besides nausea and vertigo?

A: Official uses listed by regulatory bodies include the management of mathbfpsychotic mathbfdisorders (like schizophrenia) and for the mathbfshort-term mathbfmanagement mathbfof mathbfnon-psychotic mathbfanxiety.

Q: Does Stemetil have a 'black box warning' in official documents?

A: Yes, the FDA has issued a mathbfBoxed mathbfWarning regarding an mathbfincreased mathbfrisk mathbfof mathbfdeath when antipsychotic drugs are used to treat mathbfolder mathbfadults with mathbfdementia-related mathbfpsychosis.

Q: Is Stemetil a type of antihistamine?

A: Prochlorperazine is primarily classified as a mathbfphenothiazine mathbfantipsychotic and mathbfantiemetic. However, official documents note that the compound also possesses mathbfantihistaminic mathbfproperties by blocking histamine receptors.

Q: Are there any known long-term side effects from using Stemetil?

A: The risk of developing mathbfTardive mathbfDyskinesia mathbf(TD), which may be mathbfirreversible, is noted to mathbfincrease mathbfwith mathbfthe mathbfduration mathbfof mathbftreatment and cumulative dose. Prolonged, high-dose use is also associated with the risk of changes in skin pigmentation.

Q: Can Stemetil be taken alongside herbal supplements?

A: Official information notes that there is mathbfnot mathbfenough mathbfinformation to state that all herbal remedies and supplements are safe to take with this medication. mathbfCaution is required, as some supplements may mathbfenhance mathbfthe mathbfdrug's mathbfeffects.

Q: Does Stemetil work by changing chemicals in the brain?

A: Yes, it is described as working by influencing various mathbfneurotransmitter mathbfreceptors mathbf(chemical mathbfmessengers) in the brain, primarily mathbfdopamine mathbfreceptors. This action alters chemical signaling related to mood, thought, and nausea.

Q: Can Stemetil cause weight gain?

A: Yes, mathbfweight mathbfgain is listed as a potential metabolic side effect associated with the use of this class of medication in regulatory and clinical reports.

Q: Is it normal to feel dizzy when I first start taking Stemetil?

A: mathbfDizziness and mathbfdrowsiness are commonly reported side effects. Official warnings specifically mention that this impairment is mathbfespecially mathbflikely mathbfduring mathbfthe mathbffirst mathbffew mathbfdays of therapy as the body adjusts to the medication.

Q: Can Stemetil be prescribed for symptoms related to motion sickness from travel?

A: No, official regulatory information specifically states that Prochlorperazine is mathbfineffective in treating motion sickness.

Q: Are there any official recommendations about using Stemetil and alcohol?

A: Official guidance states that Prochlorperazine mathbfuse mathbfwith mathbfethanol mathbf(alcohol) mathbfis mathbfprohibited due to the risk of mathbfintensifying mathbfcentral mathbfnervous mathbfsystem mathbfdepression.

Q: Does Stemetil carry any warnings about sun exposure?

A: Yes, the phenothiazine class of drugs may cause mathbfphotosensitivity mathbfreactions. Patients are mathbfcautioned mathbfto mathbfavoid mathbfexcessive mathbfsunlight and to use protective measures, such as sunscreen.

Q: Is Stemetil used to treat anxiety or psychiatric conditions?

A: Yes, it is formally indicated for the management of mathbfpsychotic mathbfdisorders mathbf(schizophrenia) and for the mathbfshort-term mathbfmanagement mathbfof mathbfnon-psychotic mathbfanxiety.

Q: How does the use of Stemetil differ from common anti-sickness medications?

A: It is a mathbfphenothiazine with strong mathbfdopamine mathbfantagonism, and it is mathbfnot mathbfa mathbffirst-choice anti-sickness medicine due to the risk of serious side effects like mathbfuncontrolled mathbfmuscle mathbfmovements.

Q: Are there research themes indicating Stemetil's effectiveness for specific types of nausea?

A: Research has focused on the drug's effectiveness in treating mathbfsevere mathbfnausea mathbfand mathbfvomiting for a mathbfwide mathbfrange mathbfof mathbfpathologies. This has included comparative studies often conducted in settings like the emergency department.

Q: What does official guidance say about discontinuing Stemetil?

A: Official guidance advises that after prolonged use, the dose should be mathbfreduced mathbfgradually. This is done to prevent the occurrence of mathbfwithdrawal mathbfsymptoms such as nausea, vomiting, or difficulty sleeping.

Q: Is Stemetil suitable for people with diabetes?

A: mathbfCaution mathbfis mathbfadvised for people with mathbfdiabetes. Regulatory information indicates that this medication mathbfmay mathbfdiminish mathbfthe mathbfefficacy mathbfof mathbfantidiabetic mathbfagents and mathbfinterfere mathbfwith mathbfblood mathbfglucose mathbfcontrol.

Q: Can Stemetil cause allergic reactions?

A: Yes, mathbfallergic mathbfreactions are a listed potential side effect. Furthermore, mathbfhypersensitivity to Prochlorperazine or any other phenothiazine derivative is a formal mathbfcontraindication for use.

Q: Are there any official restrictions on who can prescribe Stemetil?

A: Prochlorperazine is classified as a mathbfprescription-only mathbfmedicine (mathbfPOM). No further restrictions limiting prescribing authority to a specific class of specialist are noted in official regulatory guidance.

Q: Is Stemetil commonly used in hospital settings for post-operative recovery?

A: Its mathbfinjectable mathbfformulation is available for rapid systemic delivery. This makes it suitable for use in mathbfcontrolled mathbfsettings like hospitals for the treatment of severe nausea and vomiting.

How to Store and Dispose of Stemetil (Prochlorperazine)

Storage Requirements

Stemetil must be stored according to regulatory labeling to maintain its stability. The medication requires storage at Controlled Room Temperature, typically 20 C to 25 C. The product must be protected from light and stored in a dry place. Tablets must be kept in their original packaging or a tight, light-resistant container.

A mandatory rule for child safety requires all forms of the medicine to be kept out of the sight and reach of children.

Handling and Disposal

Prochlorperazine suppositories must not be frozen. Injection solutions should be discarded if markedly discolored.

Official disposal instructions advise users to ask a healthcare professional or pharmacist for guidance on discarding unused product. The regulatory documents explicitly state that the medicine must not be disposed of via wastewater or household waste, as this helps protect the environment.